NSE filing, NSE: CHAVDA. Summary written from the filing by ALFA Finder's alert engine.
Chavda Infra Ltd: key numbers
- Share price
- ₹45.05
- Market cap
- ₹294.2 Cr
- Revenue (annual)
- ₹320.6 Cr
- Net profit (annual)
- ₹17.00 Cr
- P/E (TTM)
- 17.3×Sector 31.3×
- Promoter holding
- 55.14%+0.02% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Chavda Infra Ltd
All →Chavda Infra Credit Rating
CARE Ratings reaffirmed the credit ratings on Chavda Infra's bank facilities aggregating to ₹105.43 Crore. The ratings reflect the company's financial profile and healthy order book.
- Value
- ₹105.4 Cr
Chavda Infra Credit Rating
Chavda Infra Limited received reaffirmed credit ratings from CARE Ratings for its bank facilities totalling ₹105.43 Crore. The rating outlook remains stable for long-term facilities.
- Value
- ₹105.4 Cr
Chavda Infra Annual General Meeting
Chavda Infra Limited held its 14th Annual General Meeting on September 29, 2026, where shareholders transacted various ordinary and special business items.
Chavda Infra Bonus Issue
Chavda Infra Limited received NSE's in-principle approval for the issuance of 3,26,56,000 bonus equity shares in a 1:1 ratio.
Chavda Infra Annual General Meeting
Chavda Infra Limited announced the successful passing of resolutions through Postal Ballot, including an increase in authorised share capital and approval for a bonus share issue.
Chavda Infra Annual Report
Chavda Infra Limited filed its 14th Annual Report for FY 2025-26 along with the Notice of the 14th Annual General Meeting scheduled for September 29, 2026.
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.